[go: up one dir, main page]

AU2001295689A1 - Compositions and methods for regulating the nervous system - Google Patents

Compositions and methods for regulating the nervous system

Info

Publication number
AU2001295689A1
AU2001295689A1 AU2001295689A AU9568901A AU2001295689A1 AU 2001295689 A1 AU2001295689 A1 AU 2001295689A1 AU 2001295689 A AU2001295689 A AU 2001295689A AU 9568901 A AU9568901 A AU 9568901A AU 2001295689 A1 AU2001295689 A1 AU 2001295689A1
Authority
AU
Australia
Prior art keywords
regulating
compositions
methods
nervous system
nervous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001295689A
Inventor
Michel Bourin
Gilles Fillion
Herve Galons
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001295689A1 publication Critical patent/AU2001295689A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001295689A 2000-10-11 2001-10-11 Compositions and methods for regulating the nervous system Abandoned AU2001295689A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR00/12983 2000-10-11
FR0012983A FR2815031A1 (en) 2000-10-11 2000-10-11 Heterocyclic and carbocyclic compounds have serotoninergic transmission modifying properties for the treatment of central and peripheral nervous disorders
PCT/FR2001/003154 WO2002030897A2 (en) 2000-10-11 2001-10-11 Compositions and methods for regulating the nervous system

Publications (1)

Publication Number Publication Date
AU2001295689A1 true AU2001295689A1 (en) 2002-04-22

Family

ID=8855209

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001295689A Abandoned AU2001295689A1 (en) 2000-10-11 2001-10-11 Compositions and methods for regulating the nervous system

Country Status (3)

Country Link
AU (1) AU2001295689A1 (en)
FR (1) FR2815031A1 (en)
WO (1) WO2002030897A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
JP2009538117A (en) * 2006-03-22 2009-11-05 ハー・ルンドベック・アクチエゼルスカベット Methods for identifying compounds for treating depression

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2988551A (en) * 1954-07-30 1961-06-13 Union Chimique Belge Sa Piperazine derivatives
GB852450A (en) * 1958-01-09 1960-10-26 Rhone Poulenc Sa New indole derivatives
US2953568A (en) * 1958-03-03 1960-09-20 Ciba Pharm Prod Inc Derivatives of piperazine
US3217011A (en) * 1965-05-07 1965-11-09 Sterling Drug Inc 1-(indolyglyoxalyl)-piperidines
FR2310763A1 (en) * 1975-05-13 1976-12-10 Buzas Andre 1,4-DISUBSTITUDE DERIVATIVES OF PIPERAZINE, THEIR PREPARATION PROCESS AND THEIR APPLICATIONS
FR2603583B1 (en) * 1986-09-05 1988-12-09 Andre Buzas BENZHYDRYLOXYETHYL-PIPERIDINE DERIVATIVES, PROCESS FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CA2015949A1 (en) * 1989-05-22 1990-11-22 Yasuo Ito Piperidine derivative, method for preparation thereof, and a pharmaceutical composition comprising the same
DK178590D0 (en) * 1990-07-26 1990-07-26 Novo Nordisk As 1,4-DISUBSTITUTED PIPERAZINES
CA2038066A1 (en) * 1990-08-09 1992-02-10 Hiroshi Fukumi (benzhydryloxyethylpiperidyl) aliphatic acid derivatives and their use in the treatment of allergies and asthma
JPH0517443A (en) * 1991-07-11 1993-01-26 Hokuriku Seiyaku Co Ltd Piperidine derivative
FR2717803B1 (en) * 1994-03-25 1996-06-21 Meram Lab Substituted derivatives of nitrogen heterocycles and their isomers, active on the central nervous system, process for obtaining them and pharmaceutical compositions containing them.
KR100389192B1 (en) * 1997-04-25 2003-06-27 다케다 야쿠힌 고교 가부시키가이샤 Condensed pyridazine derivatives, their production and use

Also Published As

Publication number Publication date
WO2002030897A2 (en) 2002-04-18
WO2002030897A3 (en) 2002-10-24
FR2815031A1 (en) 2002-04-12

Similar Documents

Publication Publication Date Title
AU2001239947A1 (en) Methods and compositions for regulating adipocytes
GB2354765B (en) Dispersion composition and method for producing the same
AU2001293189A1 (en) Compositions and methods for regulating apoptosis
AU2001243218A1 (en) Content distribution system
AU2001261779A1 (en) Improved seating system and method for making the same
AU1595900A (en) Anti-cancer compounds and methods related thereto
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
IL148803A0 (en) Novel composition and method for stabilizing the same
AU2001245288A1 (en) Overhanging form system and method of using the same
AU2002225894A1 (en) Methods and compositions for the control of coccidiosis
AU2000234340A1 (en) System for controlling and eliminating hydrogen
AU2001279850A1 (en) Method and arrangement for studsystem
AU2001263270A1 (en) Imaging-offset compensation methods and systems
AU6060099A (en) 2-substituted ketoamides
AU2001236737A1 (en) Method of reducing aluminum levels in the central nervous system
AU2002218919A1 (en) Compositions and methods for regulating receptor clustering
AU2001243635A1 (en) Methods and compositions for regulating memory consolidation
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU2001237546A1 (en) Methods for characterizing polymorphisms
AU2001251242A1 (en) Methods and compositions for regulating memory consolidation
AU2002365136A1 (en) Compositions and methods for controlled release
AU2001295689A1 (en) Compositions and methods for regulating the nervous system
AU2002322010A1 (en) Methods for regulating bacteria
AU5243899A (en) Methods and compositions for using moclobemide
EP1646395B8 (en) Methods and compositions for regulating lymphocyte activity